Bill > SB256

This bill establishes safety and care requirements for clinician-administered drugs, which are outpatient prescription drugs, excluding vaccines, that cannot be reasonably self-administered and are typically given by a healthcare professional in a clinical setting. It prohibits health insurers and pharmacy benefit managers from mandating specific pharmacies for dispensing these drugs and delivering them to a provider ("white bagging") unless there's a written agreement and provider consent. Similarly, it restricts requiring patients to transport these drugs from a pharmacy to a healthcare provider ("brown bagging") unless both the patient and provider attest that transport won't compromise care and give written consent. The bill also prevents insurers from interfering with a patient's choice of provider or pharmacy, limiting coverage based on where the drug is dispensed, or imposing additional costs on patients when drugs are not dispensed by a pharmacy chosen by the insurer. Furthermore, it ensures that providers are not penalized for obtaining these drugs from pharmacies outside the insurer's network, as long as medical necessity criteria are met.

Business and Industry, Health and Social Services

https://gc.nh.gov/bill_Status/billinfo.aspx?id=1013&inflect=2